Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E32.00 EPS (ttm)1.25 Insider Own0.04% Shs Outstand5.58B Perf Week2.99%
Market Cap222.67B Forward P/E12.83 EPS next Y3.12 Insider Trans-7.87% Shs Float5.57B Perf Month10.87%
Income6.98B PEG3.18 EPS next Q0.78 Inst Own67.60% Short Float1.09% Perf Quarter14.72%
Sales41.91B P/S5.31 EPS this Y-33.10% Inst Trans-0.02% Short Ratio2.06 Perf Half Y16.41%
Book/sh11.71 P/B3.41 EPS next Y-7.37% ROA5.70% Target Price40.69 Perf Year9.52%
Cash/sh2.19 P/C18.22 EPS next 5Y10.07% ROE14.90% 52W Range29.96 - 43.08 Perf YTD8.58%
Dividend1.56 P/FCF60.00 EPS past 5Y2.20% ROI7.60% 52W High-7.22% Beta0.73
Dividend %3.90% Quick Ratio1.00 Sales past 5Y-3.00% Gross Margin- 52W Low33.43% ATR0.73
Employees78500 Current Ratio1.40 Sales Q/Q11.80% Oper. Margin17.90% RSI (14)73.92 Volatility2.51% 1.73%
OptionableYes Debt/Eq0.63 EPS Q/Q125.10% Profit Margin22.90% Rel Volume1.83 Prev Close39.95
ShortableYes LT Debt/Eq0.59 EarningsMay 04 BMO Payout87.90% Avg Volume29.54M Price39.97
Recom2.60 SMA204.67% SMA509.99% SMA20010.54% Volume53,997,789 Change0.05%
Apr-07-21Resumed RBC Capital Mkts Sector Perform $42
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jan-23-19Downgrade UBS Buy → Neutral
May-05-21 07:00PM  
06:37PM  
06:03PM  
05:48PM  
05:22PM  
05:21PM  
05:12PM  
04:36PM  
03:49PM  
03:41PM  
03:35PM  
02:16PM  
02:06PM  
12:44PM  
11:48AM  
11:42AM  
11:30AM  
11:14AM  
10:42AM  
10:33AM  
09:12AM  
08:20AM  
07:08AM  
07:00AM  
06:30AM  
01:52AM  
May-04-21 11:01PM  
08:50PM  
06:47PM  
06:35PM  
06:29PM  
05:45PM  
05:44PM  
05:03PM  
04:59PM  
04:51PM  
04:25PM  
03:35PM  
03:18PM  
03:00PM  
02:54PM  
02:49PM  
02:44PM  
02:41PM  
02:33PM  
02:02PM  
01:48PM  
12:52PM  
11:55AM  
11:50AM  
11:39AM  
11:14AM  
10:56AM  
10:29AM  
10:24AM  
09:22AM  
09:03AM  
08:53AM  
08:31AM  
08:25AM  
08:14AM  
08:05AM  
07:45AM  
07:01AM  
06:54AM  
06:45AM  
06:22AM  
06:07AM  
03:28AM  
02:55AM  
02:26AM  
02:00AM  
01:08AM  
May-03-21 08:00PM  
08:00PM  
06:40PM  
05:36PM  
04:54PM  
04:42PM  
04:17PM  
04:14PM  
02:32PM  
02:06PM  
01:19PM  
01:03PM  
12:51PM  
12:48PM  
12:22PM  
12:11PM  
11:39AM  
11:14AM  
11:14AM  
11:13AM  
11:02AM  
09:35AM  
09:34AM  
09:00AM  
07:34AM  
07:15AM  
06:42AM  
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 27Option Exercise22.3529,838666,879153,338Mar 02 05:59 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise22.3525,165562,43895,309Mar 02 05:59 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise22.3571,8991,606,943193,474Mar 02 05:59 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise22.35129,4192,892,515575,282Mar 02 05:59 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise22.3553,9251,205,224150,172Mar 02 06:00 PM
BOURLA ALBERTChairman & CEOFeb 27Option Exercise22.3553,9251,205,224165,034Mar 02 05:34 PM
Carapezzi William R JRExecutive Vice PresidentFeb 27Option Exercise22.3521,570482,09072,522Mar 02 05:35 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27Option Exercise22.359,886220,95223,745Mar 02 05:35 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise22.35152,7853,414,745607,441Mar 02 05:35 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise22.359,886220,95234,211Mar 02 05:35 PM
SAHNI PAYALExecutive Vice PresidentFeb 25Option Exercise22.899,982228,48822,949Mar 01 04:10 PM
YOUNG JOHN DGroup PresidentFeb 25Option Exercise22.89163,3343,738,715579,791Mar 01 04:10 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise22.8981,6671,869,358189,763Mar 01 04:10 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise22.8937,658861,992100,937Mar 01 04:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25Option Exercise22.8999,8162,284,788178,092Mar 01 04:05 PM
Hwang AngelaGroup PresidentFeb 25Option Exercise22.8922,686519,28342,927Mar 01 04:01 PM
BOURLA ALBERTChairman & CEOFeb 25Option Exercise22.86163,3343,733,815245,037Mar 01 03:58 PM
Carapezzi William R JRExecutive Vice PresidentFeb 25Option Exercise22.8927,222623,11271,553Mar 01 03:58 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 25Option Exercise22.89163,3343,738,715588,584Mar 01 03:58 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25Option Exercise22.8912,477285,59919,781Mar 01 03:55 PM
BOURLA ALBERTChairman & CEONov 09Sale41.94132,5085,557,38678,273Nov 10 05:55 PM
SUSMAN SALLYExecutive Vice PresidentNov 09Sale41.9443,6621,831,184108,096Nov 10 05:55 PM
PFIZER INC10% OwnerOct 27Buy10.001,200,00012,000,00027,349,211Oct 29 05:44 PM
BLAYLOCK RONALD EDirectorAug 06Buy38.5413,000501,08513,000Aug 10 08:07 AM
DAMICO JENNIFER B.SVP & ControllerJun 05Sale36.132,18178,8007,542Jun 08 04:29 PM
Dolsten MikaelPresident R&DMay 18Sale37.7895,3533,602,681174,918May 19 05:37 PM